Additionally, how p53 mutations—frequently observed in CRC—impact amino acid-sensing mechanisms, particularly through redox regulation involving SLC7A11 and GLS2, has not been thoroughly investigated. This evidence concerns the gene GLS2 and colorectal carcinoma.